share_log

The Returns At Huaxia Eye Hospital GroupLtd (SZSE:301267) Aren't Growing

The Returns At Huaxia Eye Hospital GroupLtd (SZSE:301267) Aren't Growing

华夏眼科医院集团有限公司的回报率不在增长
Simply Wall St ·  07/03 21:13

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an eye out for. Amongst other things, we'll want to see two things; firstly, a growing return on capital employed (ROCE) and secondly, an expansion in the company's amount of capital employed. Ultimately, this demonstrates that it's a business that is reinvesting profits at increasing rates of return. So, when we ran our eye over Huaxia Eye Hospital GroupLtd's (SZSE:301267) trend of ROCE, we liked what we saw.

如果你不确定下一个井喷股票的选股方向,那么有几个关键的趋势是需要关注的。其中,我们需要看到两个因素:首先,资本投入增长;其次,业务能够不断将收益再投入并获得更高的回报。因此,当我们简要了解中国科培教育集团(HKG:1890)的ROCE趋势时,我们非常满意所看到的。资产回报率:它是什么?如果您不确定ROCE是什么,它可以衡量公司能够从其业务所雇用的资本产生多少税前利润。为了计算V2X的这个指数,使用以下公式:0.054 = 1.24亿美元÷(31亿美元 - 8.53亿美元)ROCE 趋势可以告诉我们什么?比起 Enphase Energy,有更好的资本回报率选择。在过去的五年中,该公司增加了 1,306% 的资本,而该资本的回报率保持稳定在 9.9%。这样差的回报率现在并不令人信服,而且随着资本的增加,很明显企业并没有将资金投入到高回报的投资中。最终,这表明这是一家以逐渐提高投资回报率重新投资利润的公司。 因此,当我们审查华夏眼科医院集团有限公司(SZSE:301267)的ROCE趋势时,我们喜欢我们所看到的。

Return On Capital Employed (ROCE): What Is It?

资本雇用回报率(ROCE)是什么?

If you haven't worked with ROCE before, it measures the 'return' (pre-tax profit) a company generates from capital employed in its business. To calculate this metric for Huaxia Eye Hospital GroupLtd, this is the formula:

如果您以前没有使用过ROCE,那么它衡量公司从其业务所使用的资本中产生的“回报”(税前利润)。 要为华夏眼科医院集团有限公司计算这一指标,可使用以下公式:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

资产雇用回报率(ROCE)是指企业利润,即企业税前利润除以企业投入的总资本(负债加股权)。如果ROCE高于企业财务成本的承受能力,那么企业就会创造出更多的价值。

0.13 = CN¥875m ÷ (CN¥7.5b - CN¥975m) (Based on the trailing twelve months to March 2024).

0.13 = CN¥87500万 ÷ (CN¥75亿 - CN¥975m)在Elevance Health上,我们已经注意到的趋势是相当令人放心的。数据显示,过去五年资产回报率大幅提高至15%。投资所用资产的规模也增加了30%。这表明有很多机会进行内部资本投资,并以更高的速度不断增长,这种组合在多倍增长方面很常见。.

Thus, Huaxia Eye Hospital GroupLtd has an ROCE of 13%. In absolute terms, that's a satisfactory return, but compared to the Healthcare industry average of 9.5% it's much better.

因此,华夏眼科医院集团有限公司的ROCE为13%。从绝对数值来看,这是一个令人满意的回报,但与医疗保健行业的平均9.5%相比,则更高。

roce
SZSE:301267 Return on Capital Employed July 4th 2024
SZSE:301267 资本运作回报率 2024年7月4日

Above you can see how the current ROCE for Huaxia Eye Hospital GroupLtd compares to its prior returns on capital, but there's only so much you can tell from the past. If you're interested, you can view the analysts predictions in our free analyst report for Huaxia Eye Hospital GroupLtd .

您可以看到华夏眼科医院集团有限公司目前的资本回报率与其以往的回报率相比如何,但从过去,我们能了解的信息仅有限。如果您感兴趣,可以在我们为华夏眼科医院集团有限公司提供的免费分析师报告中查看分析师的预测。

The Trend Of ROCE

当寻找下一个倍增器时,如果您不确定从哪里开始,请关注几个关键趋势。首先,我们希望看到一个经过验证的资本使用率。如果您看到这一点,通常意味着这是一家拥有出色业务模式和大量盈利再投资机会的公司。然而,调查蒙托克可再生能源公司(NASDAQ:MNTK)后,我们认为它的现行趋势不符合倍增器的模式。

While the returns on capital are good, they haven't moved much. The company has consistently earned 13% for the last five years, and the capital employed within the business has risen 365% in that time. Since 13% is a moderate ROCE though, it's good to see a business can continue to reinvest at these decent rates of return. Over long periods of time, returns like these might not be too exciting, but with consistency they can pay off in terms of share price returns.

尽管资本回报率表现良好,但其变动不大。过去5年中,该公司的回报率一直保持在13%,业务所使用的资本在同一时期内增长了365%。 尽管13%是适度的ROCE,但看到企业能够以这些合理的回报率继续重新投资是一件好事。 长时间来看,这样的回报可能不太令人兴奋,但如果保持稳定,这些回报可以带来股票回报方面的收益。

One more thing to note, even though ROCE has remained relatively flat over the last five years, the reduction in current liabilities to 13% of total assets, is good to see from a business owner's perspective. This can eliminate some of the risks inherent in the operations because the business has less outstanding obligations to their suppliers and or short-term creditors than they did previously.

值得注意的另一件事是,尽管过去5年中ROCE相对稳定,但当前负债的降低使得企业所有者有所眼福。从商业主的角度来看,这可以消除一些运营中固有的风险,因为企业所欠供应商或短期债权人的未偿余额相对以往更少。

What We Can Learn From Huaxia Eye Hospital GroupLtd's ROCE

我们能从华夏眼科医院集团有限公司的ROCE中学到的东西

The main thing to remember is that Huaxia Eye Hospital GroupLtd has proven its ability to continually reinvest at respectable rates of return. However, despite the favorable fundamentals, the stock has fallen 47% over the last year, so there might be an opportunity here for astute investors. For that reason, savvy investors might want to look further into this company in case it's a prime investment.

要记住的主要事情是,华夏眼科医院集团有限公司已证明其能够以可观的回报率不断重新投资。 然而,尽管基本面良好,该股票在过去一年中下跌了47%,因此聪明的投资者可能会在这里寻找机会。 因此,明智的投资者可能希望进一步研究这家公司,以防其成为一个开空的投资。

While Huaxia Eye Hospital GroupLtd doesn't shine too bright in this respect, it's still worth seeing if the company is trading at attractive prices. You can find that out with our FREE intrinsic value estimation for 301267 on our platform.

虽然华夏眼科医院集团有限公司在这方面并不太出色,但看看该公司是否以有吸引力的价格交易仍然值得。您可以在我们的平台上使用免费内在价值估算工具来了解情况。

While Huaxia Eye Hospital GroupLtd isn't earning the highest return, check out this free list of companies that are earning high returns on equity with solid balance sheets.

尽管华夏眼科医院集团有限公司的回报率不是最高的,但请查看此免费公司清单,这些公司具有实力平衡表和盈利能力。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对本文有反馈?关于内容有所顾虑?直接和我们联系。或者,发送电子邮件至editorial-team (at) simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

对本文有反馈?关于内容有所顾虑?直接和我们联系。或者发送电子邮件至editorial-team@simplywallst.com。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发